Сравнение методов
Просматривайте выбранные методы рядом; строки с различиями подсвечены.
| Качество жизни при эпилепсии-89 (QOLIE-89)× | Шкала Ранкина (модифицированная, mRS)× | |
|---|---|---|
| Область | Неврология | Неврология |
| Семейство | Process / pipeline | Process / pipeline |
| Год появления≠ | 1995 | 1988 |
| Автор метода≠ | Orrin Devinsky, NYU | Rankin scale original (Rankin, 1957); modified version by van Swieten et al. |
| Тип≠ | Self-report questionnaire | Clinician-rated ordinal scale |
| Основополагающий источник≠ | Devinsky, O., Vickrey, B. G., Cramer, J., Edwards, B., Perrine, K., Hamberger, M. J., & Towle, V. L. (1995). Development of the Quality of Life in Epilepsy Inventory. Epilepsia, 36(11), 1089-1104. DOI ↗ | van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988). Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 19(5), 604-607. DOI ↗ |
| Другие названия≠ | QoLIE-89 | mRS, Rankin Scale, Modified Rankin |
| Связанные≠ | 3 | 4 |
| Сводка≠ | The QOLIE-89 is a comprehensive disease-specific quality-of-life instrument developed specifically for people with epilepsy. Introduced by Devinsky and colleagues in 1995, it captures the broad impact of epilepsy on physical, emotional, social, and cognitive functioning. With 89 items organized into 17 distinct domains, it remains one of the most detailed QoL assessments for epilepsy and is widely used in clinical trials, health services research, and outcome monitoring. | The Modified Rankin Scale is a simple 0-6 ordinal measure of global disability or dependency in patients with stroke and other neurological conditions. Originally developed by Rankin in 1957 and modified by van Swieten and colleagues in 1988, it remains the most widely used global disability outcome in stroke clinical trials and clinical practice. Its simplicity, brevity, and strong prognostic association make it the gold standard for acute stroke outcome measurement and is mandated as a primary endpoint in virtually all stroke therapeutic trials. |
| ScholarGateНабор данных ↗ |
|
|